Sanfilippo type A treatment
Scope
Date
~
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Chemical Industry
Samyang launches industrial water treatment products
South Korean chemical and food company Samyang Corp. announced on Monday that it released new industrial water treatment materials Triraite Reverse ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma’s Cenobamate US patent extended by 2032
South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oc...
Nov 10, 2023 (Gmt+09:00)
-
Artificial intelligence
SK Telecom invests in AI startups Allganize, Imprimed
SK Telecom Co. has invested a combined 9.4 billion won ($7.2 million) in artificial intelligence startups Allganize Inc. and Imprimed Inc., the top ...
Nov 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Dong-A ST, UMass to jointly research for gene therapy
South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...
Nov 03, 2023 (Gmt+09:00)
-
Artificial intelligence
Socar launches car-sharing service with Naver's generative AI
South Korea’s mobility platform operator Socar Inc. has introduced a car-sharing service utilizing generative artificial intelligence in coope...
Nov 03, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Curocell to localize blood cancer drug by 2025
South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare wins Remsima order in France, Italy
South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Innovation transfers allergy treatment tech to Japan
South Korea's GI Innovation Inc. announced on Monday it has transferred its allergy treatment "GI-301" to the Japanese pharmaceutical company Maruho...
Oct 16, 2023 (Gmt+09:00)
-
Steel
Hyundai Steel aims to reduce reliance on Hyundai, Kia
South Korea's Hyundai Steel Co. is aiming to reduce its dependence on its affiliates Hyundai Motor Co. and Kia Corp. to become one of the world&rsqu...
Oct 05, 2023 (Gmt+09:00)
-
Automobiles
SUVs, small pickups grab largest share of S.Korea's car market
Sport utility vehicles (SUV) and small pickup trucks in South Korea are occupying a larger share of the domestic automotive market.Industry sources ...
Oct 04, 2023 (Gmt+09:00)
-
Batteries
LG Chem, Huayou to build LFP cathode plant in Morocco
South Korea’s LG Chem Ltd. said on Sunday it will build a lithium phosphate iron (LFP) cathode materials plant in Morocco in partnership with ...
Sep 24, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to conduct Phase 3 trials in Thailand for gout treatment
South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...
Sep 22, 2023 (Gmt+09:00)
-
Construction
Hyundai Engineering develops cutting-edge sewage treatment tech
South Korea's Hyundai Engineering Co., an engineering solutions provider for plants, architecture, infrastructure and asset management, on Wednesday...
Sep 21, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Wia finishes EV thermal management test center
South Korea’s No. 2 automotive parts supplier Hyundai Wia Corp. on Tuesday completed construction of a thermal management test center at the c...
Sep 19, 2023 (Gmt+09:00)
-
Bio & Pharma
KAIST discovers diabetes treatment using light
The Korea Advanced Institute of Science and Technology (KAIST) announced on Wednesday that they have discovered a method to treat diabetes by insert...
Sep 13, 2023 (Gmt+09:00)
-
Infrastructure
Shinhan, 3i, DWS to sell Dutch waste treatment firm to Ardian
South Korea’s Shinhan Asset Management Co., London-based 3i Group plc and Germany's DWS Group are set to sell their combined full stake in Dut...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio to sell dementia drug AR1001 in China with partner
South Korea's clinical-stage biotech company AriBio Co. on Wednesday said it signed a memorandum of understanding on strategic cooperation with Chin...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis to cooperate with Swiss firm Sandoz
Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea's Samsung Group, announced on Monday that it signed a partn...
Sep 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong gets patent of Nabota as migraine drug in US
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it has received a patent from the US Patent and Trademark Office for the use of...
Sep 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Handok to import treatment for rare autoimmune disorder
South Korean pharmaceutical company Handok Inc. on Wednesday said it signed a deal with Dutch immunology specialist Argenx to sell the latter's Vyvg...
Aug 31, 2023 (Gmt+09:00)
-
Future mobility
E-Mart24 pilot-operates drone delivery
South Korea's convenience store chain E-Mart24 Inc. is launching a commercial drone delivery service in Gimcheon, North Gyeongsang Province. This se...
Aug 28, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand